Allergy Therapeutics plc (LON:AGY) had its Corporate rating reiterated by FinnCap

Analyst Ratings For

Allergy Therapeutics plc (LON:AGY)

Story continues below

Today, FinnCap reiterated its Corporate rating on

Allergy Therapeutics plc (LON:AGY).

There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on

Allergy Therapeutics plc (LON:AGY) is Buy with a consensus target price of GBX 37.50 per share, a potential .

Some recent analyst ratings include

  • 9/25/2019-
    Allergy Therapeutics plc (LON:AGY) had its Corporate rating reiterated by FinnCap
  • 3/18/2019-
    Allergy Therapeutics plc (LON:AGY) had its Buy rating reiterated by Numis Securities with a GBX 35 price target
  • 9/28/2017-
    Allergy Therapeutics plc (LON:AGY) had its Buy rating reiterated by Panmure Gordon

    Recent Trading Activity for

    Allergy Therapeutics plc (LON:AGY)
    Shares of

    Allergy Therapeutics plc closed the previous trading session at 13.10 up +0.10 0.77% with shares trading hands.

    An ad to help with our costs